Abbvie Inc [NYSE: ABBV] traded at a low on Wednesday, posting a -0.35 loss after which it closed the day’ session at $154.79.
The results of the trading session contributed to over 4181837 shares changing hands. Over the past one week, the price volatility of Abbvie Inc stands at 1.61% while the volatility over the past one month is 1.62%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for ABBV stock reached $273.34 billion, with 1.77 billion shares outstanding and 1.76 billion shares in the current float. Compared to the average trading volume of 5.67M shares, ABBV reached a trading volume of 4181837 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Abbvie Inc [ABBV]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ABBV shares is $182.90 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ABBV stock is a recommendation set at 1.93. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Cantor Fitzgerald have made an estimate for Abbvie Inc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on May 17, 2024. The new note on the price target was released on January 29, 2024, representing the official price target for Abbvie Inc stock.
The Average True Range (ATR) for Abbvie Inc is set at 2.87, with the Price to Sales ratio for ABBV stock in the period of the last 12 months amounting to 5.02. The Price to Book ratio for the last quarter was 34.13, with the Price to Cash per share for the same quarter was set at 10.23. Price to Free Cash Flow for ABBV in the course of the last twelve months was 12.51 with Quick ratio for the last quarter at 0.83.
How has ABBV stock performed recently?
Abbvie Inc [ABBV] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -5.00. With this latest performance, ABBV shares dropped by -4.17% in over the last four-week period, additionally plugging by 11.29% over the last 6 months – not to mention a rise of 12.53% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ABBV stock in for the last two-week period is set at 30.79, with the RSI for the last a single of trading hit 25.22, and the three-weeks RSI is set at 34.31 for Abbvie Inc [ABBV]. The present Moving Average for the last 50 days of trading for this stock 166.93, while it was recorded at 157.01 for the last single week of trading, and 158.60 for the last 200 days.
Abbvie Inc [ABBV]: Deeper insight into the fundamentals
Abbvie Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.83 and a Current Ratio set at 0.94.
Earnings analysis for Abbvie Inc [ABBV]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ABBV. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Abbvie Inc go to 6.21%.
Insider trade positions for Abbvie Inc [ABBV]
The top three institutional holders of ABBV stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in ABBV stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in ABBV stock with ownership which is approximately 5.8386%.
